ITMCTR1900002466
Not yet recruiting
Phase 1
Study for the prevention and treatment of hypertensive cerebral small vessel disease by Naotaifang
Hu'nan University of Chinese Medicine0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hu'nan University of Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Agec between 40\-80 years old;
- •2\. Compliance with patients with essential hypertension;
- •3\. According to the General Consensus of Diagnosis and Treatment of Cerebral Small Vascular Diseases, MRI confirmed cerebral small vessel disease, but yes or no clinical manifestations of brain damage;
- •4\. TCM syndrome differentiation standard: refer to the Interpretation of TCM Clinical Diagnosis and Treatment Guidelines. Syndrome based on wind\-phlegm stagnant blood syndrome;
- •5\. Voluntary participation in the trial and signing of informed consent.
Exclusion Criteria
- •1\. Serious life\-threatening diseases such as acute myocardial infarction, stroke, cardiac insufficiency, grade IV, etc;
- •2\. Imaging and other diseases to exclude hypertensive cerebral small vessel disease;
- •3\. Hypertension can not be controlled by using antihypertensive drugs;
- •4\. Patients with cerebral macrovascular disease;
- •5\. Allergic or research drug known to be allergic to ingredients;
- •6\. Suspected or indeed have a history of alcohol or drug abuse, or according to the judgment of the investigator, other lesions or conditions that reduce the likelihood of enrollment or complicate the enrollment, such as frequent changes in the working environment and unstable living environment, may cause loss of follow\-up Case;
- •7\. Suffering from any serious psychological abnormalities and mental disorders, unable to comply with clinical research procedures and norms, and other researchers believe that it is not suitable for inclusion;
- •8\. Preparing a pregnant or lactating woman within one or six months of pregnancy;
- •9\. Patients who are participating in other clinical trials or have participated in other clinical trials in the past month.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Prevention for Recurrence Of The preEClampsia with TAdalafilJPRN-jRCTs041180121Tanaka Hiroaki20
Recruiting
Not Applicable
A study on Prevention of Hypertensive Disorders of Pregnancy who have a history of severe hypertensive disorders of pregnancy -Pre-test for multi center trialHypertensive Disorders of PregnancyJPRN-UMIN000027270Mie university hospital, Department of Obstetrics and Gynecology20
Recruiting
Not Applicable
The effects of therapeutic agents against hypertension, dyslipidemia or diabetes on cholesterol efflux capacity by HDL cholesterolJPRN-UMIN000005734Dept. of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University120
Active, not recruiting
Not Applicable
Prospectuve study on the treatment of normal tension glacuoma with selective laser trabeculoplastyEUCTR2014-003305-15-Outside-EU/EEAHK Clinical Trials20
Completed
Not Applicable
Research for antihypertensive prescription and office blood pressure associated home blood control in Japan, and association of orthostatic blood pressure changes with antihypertensive regimens.HypertensionJPRN-UMIN000009466Japanese Medical and Dental Practitioners for the Improvement of Medical Care20,000